Login to Your Account

FDA Experts Give Thumbs Down to Arpida, Targanta Antibiotics

By Donna Young

Friday, November 21, 2008
COLLEGE PARK, Md. - Federal advisers Thursday said Arpida AG failed to show in clinical trials that its experimental antibiotic iclaprim was safe and effective for treating patients with complicated skin and skin structure infections (cSSSIs). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription